Koninklijke Philips N.V.
PHG Healthcare Medical Devices
Koninklijke Philips N.V.’s revenue for fiscal 2025 (year ended December 2025) was $20.2 billion, up 3.47% from fiscal 2024.
- Revenue
- +0.55%
- EPS
- −85.0%
- Free cash flow
- +154.2%
- Total debt
- −4.96%
Quarter to September 2026, against a year earlier
Follow PHG
Alert me
Koninklijke Philips N.V. (PHG) P/S ratio
As of 5 November 2026, Koninklijke Philips N.V. (PHG) trades at a P/S ratio of 1.4×. Over the past ten years it has ranged from 0.4× (November 2022) to 1.9× (September 2018); the current reading is higher than 79% of that period. That is below the Medical Devices industry median of 2.5× and below the Healthcare sector median of 3.5×.
P/S ratio, daily
Embed this chart
Annual newest first
| Period | P/S ratio | Change |
|---|---|---|
| FY2025 | 1.3× | 4.25% |
| FY2024 | 1.2× | 45.51% |
| FY2023 | 0.8× | 48.06% |
| FY2022 | 0.6× | (54.41%) |
| FY2021 | 1.2× | (24.53%) |
| FY2020 | 1.6× | 34.14% |
| FY2019 | 1.2× | 14.12% |
| FY2018 | 1.1× | (28.63%) |
| FY2017 | 1.5× | 59.46% |
| FY2016 | 0.9× | 9.13% |
Quarterly newest first
| Period | P/S ratio | Change |
|---|---|---|
| Sep 2026 | 1.2× | (8.20%) |
| Jun 2026 | 1.3× | (1.05%) |
| Mar 2026 | 1.3× | 0.28% |
| Dec 2025 | 1.3× | (6.31%) |
| 37 more quarters | Free account |
Against its own ten years
P/S ratio against peers
| Company | P/S ratio |
|---|---|
| SNN Smith & Nephew SNATS, Inc. compare | 1.4× |
| PHG Koninklijke Philips N.V. | 1.4× |
| GEHC GE HealthCare Technologies Inc. compare | 1.7× |
| ZBH Zimmer Biomet Holdings, Inc. compare | 2.4× |
| BSX Boston Scientific Corporation compare | 3.1× |
| STE STERIS plc compare | 4.0× |
| DXCM DexCom, Inc. compare | 6.2× |
| EW Edwards Lifesciences Corporation compare | 8.7× |
| GKOS Glaukos Corporation compare | 18.8× |
| Medical Devices industry median | 2.5× |
| Healthcare sector median | 3.5× |
| Market median | 1.9× |
What P/S ratio is
Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.
(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)
More on PHG
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement